Diabetes mellitus is a global disease, and the number of patients with it is increasing. Of various agents for treatment, those that directly act on muscle are currently attracting attention because muscle is one of the main tissues in the human body, and its metabolism is decreased in type II diabetes. In this study, we found that hydroxylamine (HA) enhances glucose uptake in C2C12 myotubes. Analysis of HA's mechanism revealed the involvement of IRS1, PI3K and Akt that is related to the insulin signaling pathway. Further investigation about the activation mechanism of insulin receptor or IRS1 by HA may provide a way to develop a novel anti-diabetic agent alternating to insulin.
Introduction
Diabetes mellitus is a global disease, and the number of patients with it is increasing every year [1] . Diabetes mellitus is classified into two types. Type I diabetes results from a loss of insulin secretion due to the destruction of pancreatic β cells. Type II diabetes results from a reduced sensitivity to insulin and/or reduced insulin secretion from pancreatic β cells. Currently, type II diabetes is of greater concern, as it is increasing worldwide and patients with it are at increased risk of cardiovascular disease [2] , retinopathy [3] , and renal failure [4] .
In treating diabetes mellitus, control of the blood glucose level is important. Various agents have been developed to achieve this: for example, insulin therapy directly increases insulin concentration in the blood, insulin-sensitizing agents enhance the response to endogenous insulin, [5] sulfonylurea enhances insulin secretion from pancreatic β cells [6] , and α-glucosidase inhibitor attenuates the rapid elevation of blood glucose after food intake by preventing the degradation of polysaccharides in the small intestine [7] . These are quite useful agents for treating diabetes mellitus. However, because of the increasing number of patients with type II diabetes, new agents are always desired.
Skeletal muscle is one of the main tissues in the human body, constituting approximately 50% of its volume, and is known to be important in postprandial glucose homeostasis [8] . In addition, skeletal muscle cell metabolism is reported to be seriously decreased in diabetic patients [9] .
However, to the best of our knowledge, insulin and thiazolidinedione are the only agents that act directly on muscle cells to improve glucose metabolism. Thus, a number of studies have led to screening for compounds that enhance glucose metabolism in muscle cells via enhancement of glucose uptake [10] , [11] .
We found hydroxylamine (HA) as an effective compound through the screening for compounds that shows enhancement of glucose uptake against skeletal muscle cells. HA had been reported to induce enhancement of glucose uptake to L929 fibroblast through glucose transporter 1 (GLUT1) activation and the effect was induced by nitroxyl produced from HA [12] . Here, we show that the effect of HA against skeletal muscle cells does not require the generation of nitroxyl and showed that HA exerts its effect through the insulin signaling pathway.
Materials and methods

General experimental procedure
All commercially available chemicals were used without further purification. Chemicals and Luminescence was detected by LumiVision PRO 400EX (Aisin Seiki Co., Ltd., Aichi, Japan).
Luminescence intensity was quantified using Image-J software.
Cell culture
C2C12 cell was provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. C2C12 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum at 37°C in a humidified atmosphere with 10% CO 2 . Cells were reseeded in 12-well plate for immunoblotting and 48-well plate for glucose uptake assay. At 80% confluent, the medium was switched to DMEM containing 2% horse serum for differentiation. The medium was replaced every other day, and experiments were performed at 7 th day after initiating differentiation.
Glucose uptake assay
Glucose uptake assay was performed according to the reported method with modifications [13] .
The assay was done with differentiated C2C12 cells. The medium was switched to serum free For the experiments using cell signaling inhibitors (LY294002 or dorsomorphin or cytochalasin B), cells were preincubated in the presence or absence of inhibitors for 30 min. prior to sample treatment and were performed as written above.
Western blotting
The analysis was done with differentiated C2C12 cells. The medium was switched to serum free DMEM and the cells were serum starved for 1 h. To detect Akt and phosphorylated Akt, the cells were incubated with the corresponding concentration of a sample diluted in serum free DMEM for 1 h in the presence or absence of LY294002. To detect IRS1 and phosphorylated IRS1, the cells were incubated with the corresponding concentration of a sample diluted in serum free DMEM for 1, 3 or 15 min. After incubation, cells were rinsed twice with ice cold PBS. Cells were treated with cell lysis buffer (50 mM Tris/HCl, pH7.5, 150 mM NaCl, 200 mM EDTA, 4 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, 2.5 mM sodium pyrophosphate, one tablet of protease inhibitors cocktail (complete mini, Roche) per 10 ml of lysis buffer, 1.5% Triton X-100) for 5 min on ice and gently scraped. The homogenate was centrifuged at 14,000 g for 10 min. The supernatant was collected and the protein concentration was measured by Bio-Rad Protein Assay Dye Reagent Concentrate with bovine serum albumin as a standard.
The cell lysate containing 10 μg of protein was subjected to SDS-PAGE, and the separated proteins were transferred onto a PVDF membrane (GE Healthcare) with semi-dry transfer equipment. 
Statistical analysis
Each experiments were done independently three or four times. Student's t-test was used to assess the significance of difference between two mean values. P < 0.05 was considered to be statistically significant.
Results and discussion
L-cysteine works as a scavenger of nitroxyl [14, 15] . To confirm whether nitroxyl is the active molecule responsible for the enhancement of glucose uptake of HA, co-incubation experiment was performed. Addition of L-cysteine had no effect against the HA's enhancement of glucose uptake ( Figure 1 ). The result indicates that nitroxyl is not involved in HA's enhancement of glucose uptake. Major glucose transporters expressed in skeletal muscle cells are GLUT1 and GLUT4 [16] . Based on the result of figure 1, we hypothesized that GLUT4 is the major transporter responsible for the enhancement of glucose uptake of HA. To test this hypothesis, we next tested the involvement of two signaling pathways, insulin signaling pathway and AMPK signaling pathway, related to GLUT4 To further confirm whether HA exerts its effect on enhancement of glucose uptake through the insulin signaling pathway, we checked if Akt, the downstream factor of PI3K, was activated by HA.
C2C12 myotubes were exposed to HA in the presence or absence of a PI3K inhibitor. The cells were then collected, and the activation of Akt was analyzed by western blotting. The result suggests that HA induces Akt phosphorylation and that this is blocked by addition of the PI3K inhibitor ( Figure   3a ). This result supports the hypothesis that the effect of HA on enhancement of glucose uptake is induced through PI3K.
Next, we confirmed whether IRS1, the upstream factor of PI3K, is activated by HA. C2C12 myotubes were treated with HA, and the phosphorylation of IRS1 was analyzed by western blotting.
IRS1 was activated by stimulation with HA ( Figure 3b ) and therefore, HA exerts an effect in C2C12 myotubes through IRS1 or insulin receptor activation. Figure 3 Based on the above results, it is suggested that GLUT4 is the major glucose transporter responsible for enhancement of glucose uptake with HA. Finally, we checked whether HA's effect is exerted by GLUT4. Glucose uptake assay was done with cytochalasin B, the compound known to act as a inhibitor of glucose transport via glucose transporter [18, 19] . As a result, the inhibitor attenuated enhancement of glucose uptake exerted by HA (Figure 4) . From this result, we found that HA has potency of enhancement of glucose uptake via GLUT4. It is strongly suggested that enhancement of glucose uptake of HA is exerted via insulin signaling pathway. Figure 4 Of the compounds similar to HA, primary amines like benzylamine and methylamine have also been reported to show effects on enhancement of glucose uptake through the activation of IRS1 [20] , [21] . These amines are known to be substrates of semicarbazide-sensitive amine oxidase (SSAO) or monoamine oxidase (MAO), which produce hydrogen peroxide as a product of the oxidizing reaction. Released hydrogen peroxide activates IRS1 and causes GLUT4 to translocate to the cellular membrane, resulting in enhanced glucose uptake. These studies have also described that stimulation with a mixture of insulin and hydrogen peroxide had a synergistic effect on enhancement of glucose uptake [22] .
Based on the above reports, we hypothesized that HA might also activate IRS1 through the production of hydrogen peroxide. However, we subsequently rejected this hypothesis on the basis of two further experiments. First, stimulation with a mixture of insulin and HA did not have a synergistic effect (Supplementary Figure S1) ; and second, addition of a reductant (L-cysteine or glutathione), which eliminates hydrogen peroxide, did not change the activity of HA ( Figure 1 and
Supplementary Figure S2) . Thus, we suggest that activation of IRS1, and the concomitant effect on enhancement of glucose uptake, occurs via mechanisms different from those used by primary amines.
In conclusion, we found that HA is a potent enhancement of glucose uptake enhancer and showed that HA exerts its effect on enhancement of glucose uptake in skeletal muscle cells through the insulin signaling pathway. The enhancement of glucose uptake mechanism of HA was different from that of previously reported effect against L929 fibroblasts or of primary amines previously reported.
Hydroxylamines are reported to show anti-allergy and anti-inflammatory activity, and current study added the third activity effective for the treatment of diabetes mellitus [23] . Although these effects give attractiveness to HA, the compound is also known to act as a stimulant against mucosal membrane, and therefore utilization of HA as a valuable drug may be difficult. However, small molecules that directly activate IR or IRS1 are unique and interesting. Thus, by revealing its activation mechanism, novel compound that mimics the activation mechanism can be developed and utilized. In sight of this, we are currently studying the precise mechanism of HA to activate the IR or IRS1. 
